Receptors & Clinical Investigation

Receptors & Clinical Investigation is an open access, peer-reviewed, online journal that encompasses all basic and translational aspects of receptors and associated signaling pathways in normal and pathological conditions. The study of receptors including tyrosine kinases,VEGF receptor, dopamine receptor, estrogen receptors, glucocorticoids receptors, thyroid hormone receptors, Calcium Sensing Receptor, G-protein coupled receptors and T-cell receptors has been of fundamental biological interest with implications for treating a wide range of ailments including cancer, diabetes and atherosclerosis. In addition to that, ligands, coregulators, modulators, and drugs acting on receptors have been deeply studied. Our understanding of such biology has led to the discovery and use of therapeutics, including small molecule inhibitors and humanized antibodies that have been approved for treatment of cancer and ocular disease. By considering past and current advances in the field, this journal is expected to bridge receptors and associated signaling pathways with clinical investigation.

Topics of interest include but are not limited to the following areas:

  • Receptors and associated signal transduction pathways
  • Ligands
  • Corregulators
  • Drugs acting on receptors
  • Receptors as Therapeutic Targets
  • Receptors and disease


Latest Articles

Vol 4, No 1 (2017)

Table of Contents

Research highlights

Raymond Kaempfer, Andrey Popugailo, Revital Levy, Gila Arad, Dalia Hillman, Ziv Rotfogel